CASI PHARMACEUTICALS, INC. Direct Operating Costs
CASI PHARMACEUTICALS, INC. reported Direct Operating Costs of $1.86 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DirectOperatingCosts · last filed 2022-08-12
- CASI PHARMACEUTICALS, INC. direct operating costs for the quarter ending 2022-06-30 was $1.86M, a 21.34% increase year-over-year.
- CASI PHARMACEUTICALS, INC. direct operating costs for the quarter ending 2022-03-31 was $1.98M, a 59.82% increase year-over-year.
- CASI PHARMACEUTICALS, INC. direct operating costs for the quarter ending 2021-12-31 was $1.99M, a 98.31% increase year-over-year.
- CASI PHARMACEUTICALS, INC. direct operating costs for the quarter ending 2021-09-30 was $1.83M, a 80.93% increase year-over-year.
- CASI PHARMACEUTICALS, INC. direct operating costs for fiscal 2021 was $6.62M, a 0.96% increase from fiscal 2020.
- CASI PHARMACEUTICALS, INC. direct operating costs for fiscal 2020 was $6.55M.
| Period end | Direct Operating Costs 3 month | Direct Operating Costs 6 month | Direct Operating Costs 9 month | Direct Operating Costs 12 month |
|---|---|---|---|---|
| 2022-06-30 | $1.86M 10-Q · filed 2022-08-12 | $3.84M 10-Q · filed 2022-08-12 | $5.83M derived: sum of 3 quarters · filed 2022-08-12 | $7.66M derived: sum of 4 quarters · filed 2022-08-12 |
| 2022-03-31 | $1.98M 10-Q · filed 2022-05-12 | $3.97M derived: sum of 2 quarters · filed 2022-05-12 | $5.80M derived: sum of 3 quarters · filed 2022-05-12 | $7.34M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $3.82M derived: sum of 2 quarters · filed 2022-03-28 | $5.36M derived: sum of 3 quarters · filed 2022-08-12 | $6.62M 10-K · filed 2022-03-28 |
| 2021-09-30 | $1.83M 10-Q · filed 2021-11-12 | $3.37M derived: sum of 2 quarters · filed 2022-08-12 | $4.63M 10-Q · filed 2021-11-12 | $5.61M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-06-30 | $1.54M 10-Q · filed 2022-08-12 | $2.77M 10-Q · filed 2022-08-12 | $3.78M derived: sum of 3 quarters · filed 2022-08-12 | $4.79M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $1.24M 10-Q · filed 2022-05-12 | $2.24M derived: sum of 2 quarters · filed 2022-05-12 | $3.25M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $2.02M derived: sum of 2 quarters · filed 2022-03-28 | $6.55M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $1.01M 10-Q · filed 2021-11-12 | $5.55M 10-Q · filed 2021-11-12 |